FDA Approves METFORMIN HYDROCHLORIDE — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has received FDA approval for the ANDA213320, marking the approval of oral Metformin Hydrochloride, a critical expansion of its portfolio within a high-volume segment of the generics market. This move strengthens the company’s competitive positioning against peers as it captures market share in the prominent diabetic cardiovascular drug class.